Therefore, the formation of these adducts will contribute to mitochondrial dysfunction, the impairment of the axonal transport, the inhibition of the proteasomal system, the disruption of cytoskeleton architecture, and the formation of α-synuclein aggregates in PD [229]. Here, SNCA is linked to Parkinson disease.